Quick Answer
Niagen Bioscience, Inc. reported Shares Outstanding of 79.71 million shares for fiscal year 2025.
Niagen Bioscience, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 79.71M | +3.1% |
| 2024 | 77.33M | +3.1% |
| 2023 | 74.98M | +0.6% |
| 2022 | 74.57M | +9.5% |
| 2021 | 68.13M | +10.1% |
| 2020 | 61.88M | +3.9% |
| 2019 | 59.56M | +108019.6% |
| 2018 | 55,089 | -99.9% |
| 2017 | 54.70M | +45.7% |
| 2016 | 37.54M | +4.3% |
| 2015 | 36.00M | -65.8% |
| 2014 | 105.27M | +0.7% |
| 2013 | 104.52M | +13.4% |
| 2012 | 92.14M | +26.3% |
| 2011 | 72.94M | +19.8% |
| 2010 | 60.88M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 79.64M | +4.8% | +0.1% |
| June 30, 2025 | 79.59M | +5.4% | +1.5% |
| March 31, 2025 | 78.43M | +4.4% | +1.4% |
| December 31, 2024 | 77.33M | +3.1% | +1.7% |
| September 30, 2024 | 76.03M | +1.5% | +0.7% |
| June 30, 2024 | 75.47M | +0.8% | +0.4% |
| March 31, 2024 | 75.15M | +0.7% | +0.2% |
| December 31, 2023 | 74.98M | +0.6% | +0.1% |
- Niagen Bioscience, Inc. showed an increase of +3.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Niagen Bioscience, Inc.’s shares outstanding has grown by 30.9% (from 60.88 million shares to 79.71 million shares).
- The most recent figure is from Niagen Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: